JP2011521975A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521975A5
JP2011521975A5 JP2011511889A JP2011511889A JP2011521975A5 JP 2011521975 A5 JP2011521975 A5 JP 2011521975A5 JP 2011511889 A JP2011511889 A JP 2011511889A JP 2011511889 A JP2011511889 A JP 2011511889A JP 2011521975 A5 JP2011521975 A5 JP 2011521975A5
Authority
JP
Japan
Prior art keywords
transdermal patch
adhesive
drug matrix
pharmaceutically active
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011511889A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011521975A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/045762 external-priority patent/WO2009146443A1/en
Publication of JP2011521975A publication Critical patent/JP2011521975A/ja
Publication of JP2011521975A5 publication Critical patent/JP2011521975A5/ja
Pending legal-status Critical Current

Links

JP2011511889A 2008-05-30 2009-05-30 医薬化合物の経皮送達のための組成物と方法 Pending JP2011521975A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12901508P 2008-05-30 2008-05-30
US61/129,015 2008-05-30
PCT/US2009/045762 WO2009146443A1 (en) 2008-05-30 2009-05-30 Compositions and methods for the transdermal delivery of pharmaceutical compounds

Publications (2)

Publication Number Publication Date
JP2011521975A JP2011521975A (ja) 2011-07-28
JP2011521975A5 true JP2011521975A5 (enExample) 2012-07-12

Family

ID=41377621

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011511889A Pending JP2011521975A (ja) 2008-05-30 2009-05-30 医薬化合物の経皮送達のための組成物と方法

Country Status (5)

Country Link
US (1) US20090297591A1 (enExample)
EP (1) EP2291157A4 (enExample)
JP (1) JP2011521975A (enExample)
TW (1) TWI435737B (enExample)
WO (1) WO2009146443A1 (enExample)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR549901A0 (en) 2001-06-06 2001-07-12 Vital Health Sciences Pty Ltd Topical formulation containing tocopheryl phosphates
AU2002950713A0 (en) 2002-08-09 2002-09-12 Vital Health Sciences Pty Ltd Carrier
DE602005025979D1 (de) 2004-03-03 2011-03-03 Vital Health Sciences Pty Ltd Alkaloid-formulierungen
CA2611831C (en) 2005-06-17 2014-09-16 Vital Health Sciences Pty Ltd. A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US20100080842A1 (en) * 2008-09-30 2010-04-01 Jianye Wen Transdermal extended-delivery donepezil compositions and methods for using the same
EP2298277A1 (en) * 2009-09-09 2011-03-23 Labtec GmbH Transdermal patch formulation
AU2011213557B2 (en) 2010-02-05 2015-05-07 Phosphagenics Limited Carrier comprising non-neutralised tocopheryl phosphate
KR101746204B1 (ko) * 2010-02-18 2017-06-13 에스케이케미칼주식회사 피부 투과가 개선된 톨테로딘의 경피 투여용 조성물
EP2552486B1 (en) 2010-03-30 2020-08-12 Phosphagenics Limited Transdermal delivery patch
EP3517105B8 (en) * 2010-07-21 2021-06-23 Kindeva Drug Delivery L.P. Transdermal adhesive compositions, devices, and methods
US20130195957A1 (en) * 2010-08-03 2013-08-01 Hisamitsu Pharmaceutical Co., Inc. Patch and method for enhancing adhesion force of the same
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
US9561243B2 (en) 2011-03-15 2017-02-07 Phosphagenics Limited Composition comprising non-neutralised tocol phosphate and a vitamin A compound
WO2012153396A1 (ja) 2011-05-10 2012-11-15 伊藤忠ケミカルフロンティア株式会社 非水性貼付剤
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
MX367430B (es) 2011-09-27 2019-07-11 Itochu Chemical Frontier Corp Parche no acuoso.
US20130184351A1 (en) * 2011-12-21 2013-07-18 Jar Laboratories Lidocaine patch and methods of use thereof
US10195162B2 (en) 2011-12-27 2019-02-05 Teikoku Seiyaku Co., Ltd. Tolterodine-containing adhesive patch
EP2893927A4 (en) * 2012-09-03 2016-03-09 Nipro Patch Co Ltd SKIN PATCH
RU2018110325A (ru) * 2015-08-24 2019-09-26 Иточу Кемикал Фронтьер Корпорейшн Пластырь на неводной основе, содержащий лидокаин
US10973761B2 (en) 2015-12-09 2021-04-13 Phosphagenics Limited Pharmaceutical formulation
KR102647670B1 (ko) 2016-12-21 2024-03-15 아베초 바이오테크놀로지 리미티드 방법
DE102017127433A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
CN110638832A (zh) * 2019-11-07 2020-01-03 蚌埠丰原医药科技发展有限公司 一种纳米银利多卡因抗菌止痛贴及其制备方法
US20240033129A1 (en) * 2020-12-09 2024-02-01 Vizuri Health Sciences Consumer Healthcare, Inc. Highly elastic patches and masks for delivery of therapeutic agents
CN117794524A (zh) * 2021-09-09 2024-03-29 竟天生物科技股份有限公司 局部麻醉剂-粘土复合组合物
JP7179212B1 (ja) 2022-05-02 2022-11-28 久光製薬株式会社 リドカイン含有貼付剤

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2694964B2 (ja) * 1988-04-25 1997-12-24 帝國製薬株式会社 歯肉適用型局所麻酔貼付剤
US5411738A (en) * 1989-03-17 1995-05-02 Hind Health Care, Inc. Method for treating nerve injury pain associated with shingles (herpes-zoster and post-herpetic neuralgia) by topical application of lidocaine
JP3193161B2 (ja) * 1992-10-23 2001-07-30 久光製薬株式会社 経皮吸収性製剤
JP3066515B2 (ja) * 1992-11-11 2000-07-17 久光製薬株式会社 尿失禁治療用経皮投与製剤
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
US5693335A (en) * 1995-06-07 1997-12-02 Cygnus, Inc. Skin permeation enhancer composition for use with sex steroids
SE9802864D0 (sv) * 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
DE19922662C1 (de) * 1999-05-18 2000-12-28 Sanol Arznei Schwarz Gmbh Transdermales therapeutisches System (TTS) Tolterodin enthaltend
US7537785B2 (en) * 1999-10-29 2009-05-26 Nitromed, Inc. Composition for treating vascular diseases characterized by nitric oxide insufficiency
AU1585601A (en) * 1999-11-04 2001-05-14 Xel Herbaceuticals Transdermal administration of huperzine
US6562368B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of oxybutynin using hydroxide-releasing agents as permeation enhancers
JP2001302501A (ja) * 2000-04-17 2001-10-31 Oishi Koseido:Kk 肩こり・膝関節痛・五十肩等の治療用貼付剤
US20020019421A1 (en) * 2000-07-05 2002-02-14 Roni Biberman Compositions and therapy for substance addiction
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
AU2002235155A1 (en) * 2000-12-05 2002-06-18 Noven Pharmaceuticals, Inc. Crystallization inhibition of drugs in transdermal drug delivery systems
US20030124174A1 (en) * 2001-10-25 2003-07-03 Endo Pharmaceuticals, Inc Method for treating non-neuropathic pain
WO2005044242A1 (en) * 2003-10-27 2005-05-19 Dow Corning Corporation Preparations for topical application and methods of delivering an active agent to a substrate
US20050266085A1 (en) * 2004-05-28 2005-12-01 Warner Kevin S Gelled emulsion and microemulsion formulations for dermal drug delivery
ITMI20041492A1 (it) * 2004-07-23 2004-10-23 Italiano Biochimico Far Maceut Nuovo dispositivo per il rilascio di principi attivi
EP1971312A1 (en) * 2005-12-06 2008-09-24 MonoSol Rx LLC Topical film compositions for delivery of actives
US20070202155A1 (en) * 2006-02-03 2007-08-30 Cure Therapeutics, Inc. Low dose no donor-containing transdermal patch
US7879344B2 (en) * 2006-06-29 2011-02-01 Kimberly-Clark Worldwide, Inc. Transdermal delivery of oleocanthal for relief of inflammation
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
US9248104B2 (en) * 2006-08-17 2016-02-02 Core Tech Solutions, Inc. Transdermal methods and systems for treating Alzheimer's disease

Similar Documents

Publication Publication Date Title
JP2011521975A5 (enExample)
FI3257504T3 (fi) Polyvinyylipyrrolidoni ei-kidemäisessä muodossa olevan rotigotiinin kiinteän dispersion stabiloimiseksi
TWI630110B (zh) 積層型貼附劑
WO2011060256A3 (en) Bilayer tablet formulations
WO2011011318A8 (en) Process for the continuous manufacture of a polyisobutylene based transdermal patch
CN107532050B (zh) 用于透皮给药的压敏粘合剂
JP2014503523A5 (enExample)
WO2011076621A3 (de) Transdermales therapeutisches system zur verabreichung von rivastigmin oder dessen derivaten
JP2010510260A5 (enExample)
NZ610701A (en) Once daily formulation of lacosamide
WO2009113703A3 (en) Orally-disintegrating solid preparation
NZ611920A (en) Percutaneous absorption preparation containing rivastigmine
JP2016504368A5 (enExample)
WO2009008006A3 (en) Pharmaceutical compositions for gastrointestinal drug delivery
JP2013537526A5 (enExample)
JP2011521975A (ja) 医薬化合物の経皮送達のための組成物と方法
JP2012530141A5 (enExample)
JP2017515869A5 (enExample)
JP7072520B2 (ja) 二重ディスク経皮システム
EA201300704A1 (ru) Трансдермальная терапевтическая система для введения активного вещества
WO2008151040A3 (en) Analgesic coated medical product
JP2016505006A5 (enExample)
WO2011141791A3 (en) Extended release formulations of desvenlafaxine base
JP2011140504A5 (enExample)
JP2015508411A5 (enExample)